1. Home
  2. JMSB vs ALT Comparison

JMSB vs ALT Comparison

Compare JMSB & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JMSB
  • ALT
  • Stock Information
  • Founded
  • JMSB 2005
  • ALT 1997
  • Country
  • JMSB United States
  • ALT United States
  • Employees
  • JMSB N/A
  • ALT N/A
  • Industry
  • JMSB Major Banks
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • JMSB Finance
  • ALT Health Care
  • Exchange
  • JMSB Nasdaq
  • ALT Nasdaq
  • Market Cap
  • JMSB 282.0M
  • ALT 292.0M
  • IPO Year
  • JMSB N/A
  • ALT N/A
  • Fundamental
  • Price
  • JMSB $18.99
  • ALT $3.63
  • Analyst Decision
  • JMSB Buy
  • ALT Strong Buy
  • Analyst Count
  • JMSB 2
  • ALT 6
  • Target Price
  • JMSB $22.50
  • ALT $17.40
  • AVG Volume (30 Days)
  • JMSB 15.4K
  • ALT 3.0M
  • Earning Date
  • JMSB 07-23-2025
  • ALT 08-12-2025
  • Dividend Yield
  • JMSB 1.58%
  • ALT N/A
  • EPS Growth
  • JMSB 688.28
  • ALT N/A
  • EPS
  • JMSB 1.32
  • ALT N/A
  • Revenue
  • JMSB $56,750,000.00
  • ALT $20,000.00
  • Revenue This Year
  • JMSB N/A
  • ALT N/A
  • Revenue Next Year
  • JMSB N/A
  • ALT $346,228.97
  • P/E Ratio
  • JMSB $14.39
  • ALT N/A
  • Revenue Growth
  • JMSB 59.00
  • ALT N/A
  • 52 Week Low
  • JMSB $13.81
  • ALT $2.90
  • 52 Week High
  • JMSB $26.52
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • JMSB 50.78
  • ALT 40.61
  • Support Level
  • JMSB $18.85
  • ALT $3.34
  • Resistance Level
  • JMSB $19.75
  • ALT $3.91
  • Average True Range (ATR)
  • JMSB 0.44
  • ALT 0.20
  • MACD
  • JMSB 0.02
  • ALT 0.06
  • Stochastic Oscillator
  • JMSB 56.07
  • ALT 42.69

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: